Novartis to speed access to $10 billion heart drug via NHS deal
Novartis and Britain's National Health Service (NHS) on Monday announced a pact that will clear the way for accelerated review by the country's health watchdog NICE for heart drug inclisiran, which could make it broadly available as soon as 2021.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news